Many steatosis-increasing variants were also associated with cirrhosis, including those in PNPLA3, TM6SF2, and MBOAT7 at a genome-wide level of significance, and suggestive at APOE, HSD17B13, MARC1, and SERPINA1 (45). Here, PNPLA3 is linked to steatosis.